These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33453797)

  • 41. Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood.
    Valbuena H; Shipkova M; Kliesch SM; Müller S; Wieland E
    Clin Chem Lab Med; 2016 Mar; 54(3):437-46. PubMed ID: 26351941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of Immunosuppressant Drugs in Whole Blood by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Pablo AH; Breaud AR; Clarke W
    Curr Protoc Toxicol; 2020 Jun; 84(1):e92. PubMed ID: 32436620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of UHPLC-MS/MS method for simultaneous determination of tacrolimus and sirolimus in human whole blood and comparisons with two immunoassays.
    Liu B; Geng N; Zhao H; Tao Y; Hu L; Huang L; Feng Y
    Biomed Chromatogr; 2023 Feb; 37(2):e5538. PubMed ID: 36271903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a batched-extraction method for measurement of sirolimus, tacrolimus, and cyclosporine on the Architect i2000SR.
    Di Meo A; Youkhana S; Khalifeh S; Brinc D
    Clin Chim Acta; 2022 Jun; 531():230-236. PubMed ID: 35390337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous quantification of tacrolimus and sirolimus, in human blood, by high-performance liquid chromatography-tandem mass spectrometry.
    Taylor PJ; Salm P; Lynch SV; Pillans PI
    Ther Drug Monit; 2000 Oct; 22(5):608-12. PubMed ID: 11034268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of non-contact hematocrit prediction technologies to overcome hematocrit effects on immunosuppressant quantification from dried blood spots.
    Deprez S; Heughebaert L; Boffel L; Stove CP
    Talanta; 2023 Mar; 254():124111. PubMed ID: 36462285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine.
    Hörber S; Peter A; Lehmann R; Hoene M
    Clin Chem Lab Med; 2021 Apr; 59(5):913-920. PubMed ID: 33068377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective use of liquid chromatography-mass spectrometry (LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine.
    Poquette MA; Lensmeyer GL; Doran TC
    Ther Drug Monit; 2005 Apr; 27(2):144-50. PubMed ID: 15795643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A direct method for the measurement of everolimus and sirolimus in whole blood by LC-MS/MS using an isotopic everolimus internal standard.
    Morgan PE; Brown NW; Tredger JM
    Ther Drug Monit; 2014 Jun; 36(3):358-65. PubMed ID: 24305629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood.
    Streit F; Armstrong VW; Oellerich M
    Clin Chem; 2002 Jun; 48(6 Pt 1):955-8. PubMed ID: 12029019
    [No Abstract]   [Full Text] [Related]  

  • 51. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
    McMillin GA; Johnson-Davis K; Dasgupta A
    Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
    J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems.
    Koster RA; Veenhof H; Botma R; Hoekstra AT; Berger SP; Bakker SJ; Alffenaar JC; Touw DJ
    Bioanalysis; 2017 Apr; 9(7):553-563. PubMed ID: 28300419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of a small particle solid-core packing for improved efficiency and rapid measurement of sirolimus and everolimus by LC-MS/MS.
    Morgan P; Nwafor M; Tredger M
    Biomed Chromatogr; 2016 Jun; 30(6):983-5. PubMed ID: 26419504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a Simple and Rapid Method to Measure the Free Fraction of Tacrolimus in Plasma Using Ultrafiltration and LC-MS/MS.
    Stienstra NA; Sikma MA; van Dapperen AL; de Lange DW; van Maarseveen EM
    Ther Drug Monit; 2016 Dec; 38(6):722-727. PubMed ID: 27805928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of LC-MS/MS and chemiluminescent immunoassays for immunosuppressive drugs reveals organ dependent variation in blood cyclosporine a concentrations.
    Becker A; Backman JT; Itkonen O
    Clin Chim Acta; 2020 Sep; 508():22-27. PubMed ID: 32387638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS.
    Sadilkova K; Busby B; Dickerson JA; Rutledge JC; Jack RM
    Clin Chim Acta; 2013 Jun; 421():152-6. PubMed ID: 23473895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunosuppressive Drug Measurement by Liquid Chromatography Coupled to Tandem Mass Spectrometry: Interlaboratory Comparison in the Korean Clinical Laboratories.
    Kim HK; Park HD; Lee SG; Chae H; Song SH; Lee YW; Yun YM; Ahn S; Kim S; Lee SM; Lee SY; Chun S;
    Ann Lab Med; 2021 May; 41(3):268-276. PubMed ID: 33303711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a cyano stationary phase for the determination of tacrolimus, sirolimus and cyclosporin A in whole blood by high-performance liquid chromatography-tandem mass spectrometry.
    Hatsis P; Volmer DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 809(2):287-94. PubMed ID: 15315778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimus.
    Sato E; Yano I; Shimomura M; Masuda S; Katsura T; Matsumoto S; Okitsu T; Iwanaga Y; Uemoto S; Inui K
    Drug Metab Pharmacokinet; 2009; 24(2):175-9. PubMed ID: 19430174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.